Biondo Investment Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$1.84M |
| 2 |
Idexx Laboratories
IDXX
|
+$901K |
| 3 |
SIVB
SVB Financial Group
SIVB
|
+$555K |
| 4 |
Illumina
ILMN
|
+$506K |
| 5 |
XYZ
Block Inc
XYZ
|
+$392K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$412M |
| 2 |
Wells Fargo
WFC
|
+$643K |
| 3 |
Amazon
AMZN
|
+$316K |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$275K |
| 5 |
ExxonMobil
XOM
|
+$202K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.21% |
| 2 | Technology | 19.59% |
| 3 | Financials | 10.81% |
| 4 | Consumer Discretionary | 9.28% |
| 5 | Energy | 6.07% |
Similar funds
Biondo Investment Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Biondo Investment Advisors held 76 positions worth $434M, down 4.5% from $454M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Biondo Investment Advisors withdrew a net $404M in Q3 2022, closing 2 positions and reducing 8 holdings. Its most notable exit was Wells Fargo, an estimated $643K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 30% a quarter earlier, followed by Technology and Financials.
Against the trend, Biondo Investment Advisors added an estimated $1.84M to Shockwave Medical, Inc. Common Stock.
- Biondo Investment Advisors added most to Shockwave Medical, Inc. Common Stock in Q3 2022, an estimated $1.84M increase.
- Biondo Investment Advisors's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $412M.
- Biondo Investment Advisors fully exited Wells Fargo in Q3 2022, selling an estimated $643K.
- Biondo Investment Advisors's ten largest holdings make up 43% of its $434M portfolio in Q3 2022.
- Biondo Investment Advisors opened 0 new positions and closed 2 in Q3 2022.
- Biondo Investment Advisors's portfolio value fell 4.5% quarter-over-quarter to $434M.
Based on Biondo Investment Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.